Business
AstraZeneca COVID-19 vaccine trial volunteer ‘had neurological symptoms’ – Sydney Morning Herald
A woman in the trial in the UK had symptoms consistent with a rare but serious spinal inflammatory disorder, according to a report.
AstraZeneca said a woman in the United Kingdom had symptoms consistent with a rare but serious spinal inflammatory disorder, which led to the British drugmaker’s decision to stop its clinical study of the new coronavirus vaccine, Stat News has reported.
The participant was recovering and will likely be discharged from the hospital within a day, according to Stat News, which said on Wednesday the new disclosures by Astra Chief Executive Pascal Soriot were shared by three of the investors partici…
-
General21 hours agoEpstein files contain new photo of former prince Andrew Mountbatten-Windsor
-
Noosa News21 hours agoGreen spine to open in early 2026, stations to sit empty after completion next year
-
Noosa News5 hours agoLight plane crashes in Norwell, Gold Coast
-
Business7 hours agoThese 3 ASX ETFs are all a beginner needs